asymmetrical flow field-flow fractionation af2000 Search Results


asymmetric flow field flow fractionation af4 characterization  (Postnova Analytics)
86
Postnova Analytics asymmetric flow field flow fractionation af4 characterization
Figure 1. Schematics and characterization of polyphosphazenes (PZ)/protein complexes. (A) Chemi- cal structures of PZ-PYR and PZ-PEG polymers and their schematic presentations. (B) Representative <t>AF4</t> profiles of FITC-avidin, PZ-PYR, and PZ-PYR/FITC-avidin as detected at 495 nm (PZ-PYR profile at 210 nm detection is shown for comparison purposes). (C) Dynamic light scattering profiles of FITC-avidin, PZ-PYR, and PZ-PYR/FITC-avidin (25 mM phosphate buffer, pH 7.4). (D) Efficiency of protein or peptide binding to PZ-PEG and PZ-PYR expressed as a percent of bound molecules of their total amount for FITC-avidin, Bax-BH3 peptide, and anti-F-actin antibody (25 mM phosphate buffer, pH 7.4).
Asymmetric Flow Field Flow Fractionation Af4 Characterization, supplied by Postnova Analytics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/asymmetric flow field flow fractionation af4 characterization/product/Postnova Analytics
Average 86 stars, based on 1 article reviews
asymmetric flow field flow fractionation af4 characterization - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Figure 1. Schematics and characterization of polyphosphazenes (PZ)/protein complexes. (A) Chemi- cal structures of PZ-PYR and PZ-PEG polymers and their schematic presentations. (B) Representative AF4 profiles of FITC-avidin, PZ-PYR, and PZ-PYR/FITC-avidin as detected at 495 nm (PZ-PYR profile at 210 nm detection is shown for comparison purposes). (C) Dynamic light scattering profiles of FITC-avidin, PZ-PYR, and PZ-PYR/FITC-avidin (25 mM phosphate buffer, pH 7.4). (D) Efficiency of protein or peptide binding to PZ-PEG and PZ-PYR expressed as a percent of bound molecules of their total amount for FITC-avidin, Bax-BH3 peptide, and anti-F-actin antibody (25 mM phosphate buffer, pH 7.4).

Journal: Pharmaceutics

Article Title: Intracellular Delivery of Active Proteins by Polyphosphazene Polymers.

doi: 10.3390/pharmaceutics13020249

Figure Lengend Snippet: Figure 1. Schematics and characterization of polyphosphazenes (PZ)/protein complexes. (A) Chemi- cal structures of PZ-PYR and PZ-PEG polymers and their schematic presentations. (B) Representative AF4 profiles of FITC-avidin, PZ-PYR, and PZ-PYR/FITC-avidin as detected at 495 nm (PZ-PYR profile at 210 nm detection is shown for comparison purposes). (C) Dynamic light scattering profiles of FITC-avidin, PZ-PYR, and PZ-PYR/FITC-avidin (25 mM phosphate buffer, pH 7.4). (D) Efficiency of protein or peptide binding to PZ-PEG and PZ-PYR expressed as a percent of bound molecules of their total amount for FITC-avidin, Bax-BH3 peptide, and anti-F-actin antibody (25 mM phosphate buffer, pH 7.4).

Article Snippet: Asymmetric Flow Field Flow Fractionation (AF4) characterization was conducted using Postnova AF2000 MT series instrument (Postnova Analytics, Landsberg, Germany) equipped with UV-Vis detector (SPD-20A/20AV, Shimadzu Scientific Instruments, Columbia, MD, USA) and regenerated cellulose membrane (10 kDa molecular weight cutoff, Postnova Analytics, Landsberg, Germany).

Techniques: Avidin-Biotin Assay, Comparison, Binding Assay